This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Clorox Hits 52-Week High on Increased Demand for Disinfectant
by Zacks Equity Research
Clorox (CLX) gains from the increased demand for disinfectants after the coronavirus outbreak. Also, the company is witnessing strong progress in the core International business.
John Wiley (JW.A) Stock Up on Q3 Earnings Beat & Raised View
by Zacks Equity Research
John Wiley & Sons' (JW.A) third-quarter fiscal 2020 results reflect strength in Research Publishing & Platforms, Education Services and Education Services and Academic & Professional Learning units.
Campbell Soup's (CPB) Q2 Earnings, Revenues Top Estimates
by Zacks Equity Research
Campbell Soup's (CPB) second-quarter fiscal 2020 earnings increase on the back of higher adjusted EBIT and lower interest expenses.
3 Factors That Make Lamb Weston (LW) an Attractive Stock
by Zacks Equity Research
Lamb Weston's (LW) focus on initiatives to boost offerings and operating capacity bodes well. Further, the company is gaining from its LTO innovation.
Inter Parfums (IPAR) Q4 Earnings Meet Estimates, View Down
by Zacks Equity Research
Inter Parfums' (IPAR) Q4 results benefit from growth in U.S.-based operations. However, outbreak of coronavirus is likely to impact the company's performance in 2020.
Sanderson Farms' (SAFM) Loss Wider Than Estimates in Q4
by Zacks Equity Research
Sanderson Farms' (SAFM) fourth-quarter fiscal 2019 improves year over year. Nevertheless, the company is optimistic about demand and prices for its poultry products in 2020.
Kimberly-Clark (KMB) Up on Solid Restructuring & Innovation
by Zacks Equity Research
Kimberly-Clark's (KMB) focus on restructuring programs, product innovation and cost-saving plans bode well. However, the K-C Professional business looks troubled.
Colgate (CL) Gains From Growth Strategies, Cost Woes Persist
by Zacks Equity Research
Colgate (CL) is benefiting from innovation plans, savings program and expansion strategies. However, increased raw material costs, higher SG&A expenses and currency woes remain concerns.
e.l.f. Beauty, Inc. (ELF)Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor e.l.f. Beauty, Inc. (ELF).
What's in Store for Service Corporation's (SCI) Q4 Earnings?
by Zacks Equity Research
Benefits from efforts to drive preneed sales and lower G&A costs are likely to get reflected in Service Corporation's (SCI) fourth-quarter 2019 results. However, certain headwinds in China are a threat.
Nu Skin's (NUS) Q4 Earnings Meet Estimates, Down Year on Year
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2019 results reflect lower earnings and sales. Further, management expects the coronavirus outbreak to hurt Mainland China sales in 2020.
International Flavors' (IFF) Q4 Earnings & Sales Top Estimates
by Zacks Equity Research
International Flavors (IFF) registers high-single digit currency neutral sales growth and stellar double-digit adjusted EPS growth in Q4.
Bed Bath & Beyond Stock Tanks on Soft Q4 Performance Update
by Zacks Equity Research
Bed Bath & Beyond (BBBY) provides fourth-quarter fiscal 2019 performance update. The company is facing short-term headwinds in its efforts to stabilize the business.
Here's Why Hershey (HSY) is an Attractive Pick for Investors
by Zacks Equity Research
Hershey (HSY) has been undertaking buyouts to augment portfolio and expand in the snacking category. Also, the company's focus on enhancing operating efficiency bodes well.
Here's How Kraft Heinz (KHC) Looks Ahead of Q4 Earnings
by Zacks Equity Research
Impacts of volatile prices as well as cost inflation in meats and cheese category are likely to get reflected in Kraft Heinz's (KHC) fourth-quarter 2019 results.
Best of the Beauty and Social Media Earnings Charts
by Tracey Ryniec
Who has the best chart of the beauty and social media companies reporting this week?
E.l.f. Beauty (ELF) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
e.l.f. Beauty (ELF) delivered earnings and revenue surprises of 50.00% and 5.68%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
E.l.f. Beauty (ELF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
E.l.f. Beauty (ELF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Colgate (CL) Retain Its Positive Earnings Trend in Q4?
by Zacks Equity Research
Colgate's (CL) fourth-quarter 2019 results are likely to reflect benefits from its accelerated investment in brands, higher pricing, robust volume growth and strong innovation.
Corteva (CTVA) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Corteva's (CTVA) Q4 performance is likely to have benefited from cost-saving initiatives. However, softness in the North American market poses threat.
Why the Earnings Surprise Streak Could Continue for e.l.f. Beauty (ELF)
by Zacks Equity Research
e.l.f. Beauty (ELF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Tyson Foods Protein-Packed Brands Solid, Cost Woes Prevail
by Zacks Equity Research
Tyson Foods (TSN) is focused on enhancing portfolio to capitalize on the rising demand for protein-packed products. However, rising input costs are a concern.
Here's What You Should Note Ahead of Altria (MO) Q4 Earnings
by Zacks Equity Research
Altria's (MO) fourth-quarter 2019 results are likely to reflect gains from pricing and RRPs amid soft cigarette volumes.
Lamb Weston Looks Promising on LTO Focus & Solid Price/Mix
by Zacks Equity Research
Lamb Weston (LW) is focused on efficient price/mix, buyouts and capacity expansion efforts. Further, the company is gaining from its LTO innovation.
What's in Store for Procter & Gamble (PG) in Q2 Earnings?
by Zacks Equity Research
Procter & Gamble's (PG) second-quarter fiscal 2020 results are likely to reflect gains from organic sales and growth initiatives. Adverse currency might have been a drag.